COVID 19 and melanoma

Mar 16, 2020 | COVID19 | 0 comments

cancer immunotherapy does not increase the risk of death by COVID 19 in melanoma patients

Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach

The Danger of Neglecting Melanoma during the COVID-19 Pandemic

COVID 19. practical and immuno oncology insight in melanoma and beyond

national comprehensive cancer network.short term recommendations for cutaneous melanoma management during COVID 19 pandemic

the importance of self- examination for melanoma prevention during the COVID 19 pandemic. an interview with june robinson

ESMO management and treatment adapted recommendations in the COVID 19 era. melanoma

MSSS [QC] recommandations pour la priorisation des patients en contexte de pandémie de COVID-19 – Volet Mélanome

Submit a Comment Cancel reply